Ramos-Figueroa Josseline S, Zhu Lingyang, Halliman Matthew, van der Donk Wilfred A
Department of Chemistry and Howard Hughes Medical Institute, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.
School of Chemical Sciences NMR Laboratory, University of Illinois at Urbana-Champaign, Urbana, 61801, IL, USA.
bioRxiv. 2025 Sep 6:2025.09.03.674030. doi: 10.1101/2025.09.03.674030.
Ammosamide C is a marine natural product containing a highly decorated pyrroloiminoquinone core. Studies on the biosynthetic gene cluster (BGC) that produces ammosamides previously revealed that they are made by a series of posttranslational modifications (PTMs). The BGC includes genes encoding a precursor peptide AmmA and four enzymes known as PEptide Aminoacyl-tRNA Ligases (PEARLs). Initial studies into the ammosamide biosynthetic pathway demonstrated Trp addition to a precursor peptide by the PEARL AmmB. Thereafter, sequential modifications by several enzymes including two other PEARLs lead to the formation of a peptide intermediate bearing a C-terminal diaminoquinone. In the present work, we present the biosynthetic steps that convert this intermediate to ammosamide C. The PEARL AmmB unexpectedly appends an arginine to the C-terminus of the aforementioned intermediate. Then, C-terminal proteolysis by the heterodimeric TldD/E-like protease Amm12/13 releases a dipeptide, which is subsequently cleaved by the dipeptidase Amm19 to produce a Trp-derived diaminoquinone. Amm3 next catalyzes the conversion of this Trp derivative to the corresponding chlorinated ammosamaic acid. Finally, Amm23 methylates this intermediate and a putative aminotransferase Amm20 performs an amidation to arrive at ammosamide C; the order of these last two steps could not be determined. This study reveals an unexpectedly lengthy route to ammosamide that illustrates the opportunistic nature of natural product biosynthesis, demonstrates a role for a PEARL that is unlike previous roles, identifies steps that are not PTMs, and adds Arg-tRNA to the growing repertoire of amino acyl tRNAs that are used by PEARLs.
氨莫酰胺C是一种海洋天然产物,含有高度修饰的吡咯并亚氨基醌核心。先前对产生氨莫酰胺的生物合成基因簇(BGC)的研究表明,它们是通过一系列翻译后修饰(PTM)形成的。该BGC包括编码前体肽AmmA的基因和四种被称为肽氨酰-tRNA连接酶(PEARL)的酶。对氨莫酰胺生物合成途径的初步研究表明,PEARL AmmB将色氨酸添加到前体肽上。此后,包括另外两种PEARL在内的几种酶的顺序修饰导致形成带有C端二氨基醌的肽中间体。在本研究中,我们展示了将该中间体转化为氨莫酰胺C的生物合成步骤。PEARL AmmB意外地将精氨酸添加到上述中间体的C端。然后,异源二聚体TldD/E样蛋白酶Amm12/13进行C端蛋白水解,释放出一种二肽,随后该二肽被二肽酶Amm19切割,产生一种色氨酸衍生的二氨基醌。接下来,Amm3催化这种色氨酸衍生物转化为相应的氯化氨莫酸。最后,Amm23使该中间体甲基化,一种推定的转氨酶Amm20进行酰胺化反应生成氨莫酰胺C;最后这两步的顺序无法确定。这项研究揭示了一条通往氨莫酰胺的出人意料的漫长途径,说明了天然产物生物合成的机会主义性质,证明了一种与以往作用不同的PEARL的作用,确定了非PTM的步骤,并将精氨酰-tRNA添加到PEARL使用的不断增加的氨酰tRNA库中。